Correction to “MMP9 Knockout by CRISPR-Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti-PD-L1 in an Orthotopic Mouse Model”

IF 3.2 3区生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

IUBMB Life Pub Date : 2026-10-09 DOI:10.1002/iub.70134

引用次数: 0

Abstract

J. A. D. Camargo, M. C. Lee, M. M. D. Souza, et al., “ MMP9 Knockout by CRISPR-Cas9 Reduces Bladder Cancer Malignancy But Does Not Synergize With BCG and Anti-PD-L1 in an Orthotopic Mouse Model,” IUBMB Life 78, no. 9 (2026): e70130, https://doi.org/10.1002/iub.70130.

In the originally published article, author Giovana Vilas Boas Caetano was incorrectly given as Giovana Caetano Vilas Boas. The online version of the article has been updated.

We apologize for this error.

查看原文本刊更多论文

更正“在原位小鼠模型中，CRISPR-Cas9敲除MMP9可降低膀胱癌恶性，但不与BCG和抗pd - l1协同”。

J. A. D. Camargo， M. C. Lee， M. M. D. Souza等，“通过CRISPR-Cas9敲除膀胱癌恶性肿瘤但不与卡介苗和抗pd - l1协同作用的小鼠模型”，中国生物医学工程学报，第78期，no。9 (2026): e70130, https://doi.org/10.1002/iub.70130。在最初发表的文章中，作者Giovana Vilas Boas Caetano被错误地称为Giovana Caetano Vilas Boas。文章的在线版本已经更新。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

IUBMB Life 生物-生化与分子生物学

CiteScore

10.60

自引率

0.00%

发文量

109

审稿时长

4-8 weeks

期刊介绍： IUBMB Life is the flagship journal of the International Union of Biochemistry and Molecular Biology and is devoted to the rapid publication of the most novel and significant original research articles, reviews, and hypotheses in the broadly defined fields of biochemistry, molecular biology, cell biology, and molecular medicine.